| Product Code: ETC8563195 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, New Zealand saw an increase in the import of medical cannabis, with top exporting countries including Australia, Metropolitan France, Spain, Ireland, and Germany. Despite this growth, the market remains relatively fragmented with low concentration levels, indicated by a low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 3.11%, although there was a slight decline in growth rate from 2023 to 2024 at -16.18%. This data suggests a growing interest in medical cannabis imports in New Zealand, with diverse sources contributing to the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Legalized Cannabis Medical Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Legalized Cannabis Medical Market Revenues & Volume, 2022 & 2032F |
3.3 New Zealand Legalized Cannabis Medical Market - Industry Life Cycle |
3.4 New Zealand Legalized Cannabis Medical Market - Porter's Five Forces |
3.5 New Zealand Legalized Cannabis Medical Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 New Zealand Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.7 New Zealand Legalized Cannabis Medical Market Revenues & Volume Share, By End Use, 2022 & 2032F |
3.8 New Zealand Legalized Cannabis Medical Market Revenues & Volume Share, By Compound, 2022 & 2032F |
4 New Zealand Legalized Cannabis Medical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 New Zealand Legalized Cannabis Medical Market Trends |
6 New Zealand Legalized Cannabis Medical Market, By Types |
6.1 New Zealand Legalized Cannabis Medical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Herb, 2022 - 2032F |
6.1.4 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Resin, 2022 - 2032F |
6.2 New Zealand Legalized Cannabis Medical Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Raw, 2022 - 2032F |
6.2.3 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Processed, 2022 - 2032F |
6.3 New Zealand Legalized Cannabis Medical Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Recreational, 2022 - 2032F |
6.3.3 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Medicinal, 2022 - 2032F |
6.4 New Zealand Legalized Cannabis Medical Market, By Compound |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By THC-Dominant, 2022 - 2032F |
6.4.3 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By CBD-Dominant, 2022 - 2032F |
6.4.4 New Zealand Legalized Cannabis Medical Market Revenues & Volume, By Balanced THC & CBD, 2022 - 2032F |
7 New Zealand Legalized Cannabis Medical Market Import-Export Trade Statistics |
7.1 New Zealand Legalized Cannabis Medical Market Export to Major Countries |
7.2 New Zealand Legalized Cannabis Medical Market Imports from Major Countries |
8 New Zealand Legalized Cannabis Medical Market Key Performance Indicators |
9 New Zealand Legalized Cannabis Medical Market - Opportunity Assessment |
9.1 New Zealand Legalized Cannabis Medical Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 New Zealand Legalized Cannabis Medical Market Opportunity Assessment, By Form, 2022 & 2032F |
9.3 New Zealand Legalized Cannabis Medical Market Opportunity Assessment, By End Use, 2022 & 2032F |
9.4 New Zealand Legalized Cannabis Medical Market Opportunity Assessment, By Compound, 2022 & 2032F |
10 New Zealand Legalized Cannabis Medical Market - Competitive Landscape |
10.1 New Zealand Legalized Cannabis Medical Market Revenue Share, By Companies, 2025 |
10.2 New Zealand Legalized Cannabis Medical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here